Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly claims new opioid antagonists with utility in obesity and related disorders

Jan. 19, 2004

New etonogestrel esters and their use presented by Akzo Nobel scientists

Jan. 19, 2004

JT team presents MTP inhibitors devoid of hepatic side effects

Jan. 19, 2004

Amgen claims two series of calcium channel modulators for bone and PTH disorders

Jan. 19, 2004

Innovative Companies files patent for method to stabilize levothyroxine

Jan. 19, 2004

Kyorin Pharmaceutical to tie up with ActivX Bioscience

Jan. 19, 2004

NIP-222, a novel PPARgamma agonist for diabetic nephropathy

Jan. 16, 2004

Magnesium intake and risk of type 2 diabetes in healthy adult women

Jan. 16, 2004

Letrozole reduces the need for gonadotropins in infertile women undergoing IUI

Jan. 16, 2004

Aastrom Biosciences evaluates Tissue Repair Cell product for tibial fractures

Jan. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...